Anti-ACADL antibodies are used in the immunodetection of the protein acyl-CoA dehydrogenase long chain. In humans, the canonical protein has a reported length of 430 amino acid residues and a mass of 47.7 kDa. Its subcellular localization is in the mitochondria. It is notably expressed in many tissues, such as the kidney and lung. A member of the Acyl-CoA dehydrogenase protein family, ACADL is known to be involved with the metabolism of lipids. Post-translational modifications have been described, including acetylation. Synonyms for this target antigen include LCAD, long-chain specific acyl-CoA dehydrogenase, mitochondrial, acyl-Coenzyme A dehydrogenase, long chain, long-chain acyl-CoA dehydrogenase, and ACAD4. ACADL gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of ACADL antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. Immunofluorescence and Immunohistochemistry are also common applications.